Canine Gallbladder Disease: Diagnostic and Therapeutic Approach

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Abdominal ultrasound is the primary diagnostic modality for canine gallbladder disease, assessing wall thickness (<2mm normal), luminal content (mucocele staging), and biliary duct diameter.
• Gallbladder mucocele, characterized by progressive mucus accumulation and impaired motility, can lead to ischemia, necrosis, and rupture, necessitating surgical intervention in advanced stages.
• Cholecystitis, either sterile or bacterial, requires differentiation; bacterial cholecystitis often involves enteric organisms, and bile culture via cholecystocentesis is crucial for targeted antimicrobial therapy.
• Medical management focuses on reducing bile stasis with ursodeoxycholic acid (UDCA) and controlling infection with appropriate antimicrobials, while SAMe offers hepatoprotective benefits.
• Surgical intervention (cholecystectomy) is indicated for gallbladder rupture, extrahepatic biliary obstruction, progressive mucoceles, or failure of medical therapy, with prognosis dependent on promptness and severity of complications like bile peritonitis.
• Diagnostic errors include over-reliance on gallbladder appearance alone, treating sludge as an automatic surgical indication, misinterpreting bile acid testing for biliary staging, and delaying surgical referral in deteriorating patients.

Gallbladder disease in dogs spans a spectrum from incidental ultrasonographic findings to life-threatening biliary obstruction and rupture. The clinical challenge lies in distinguishing patients that require medical management from those that need urgent surgical intervention. This article provides a systematic framework for diagnosing and treating canine gallbladder disorders, with emphasis on gallbladder mucocele and cholecystitis. It serves practicing veterinarians who need decision criteria for imaging interpretation, laboratory evaluation, medical therapy, and surgical referral. Hepatic parenchymal disease is excluded from this discussion except where it directly complicates biliary tract disease.

The diagnostic approach begins with recognition that biliary tract disease often mimics other intra-abdominal disorders. Historical signs, physical examination findings, and clinicopathologic abnormalities overlap considerably with pancreatitis, gastrointestinal disease, and peritonitis of other origins. As a review of disorders of the gallbladder and extrahepatic biliary tract in the dog and cat notes, this clinical similarity contributes to diagnostic confusion and delayed recognition. A structured approach that integrates ultrasonography, bile acid assessment, and cytologic or histopathologic evaluation is therefore essential.

At a Glance

Physiology of Bile Formation and Flow

Bile is produced continuously by hepatocytes and modified by cholangiocytes as it passes through the biliary tree. The gallbladder concentrates bile through mucosal water absorption, increasing solute concentration and promoting cholesterol crystallization under pathologic conditions. Gallbladder contraction is stimulated by cholecystokinin in response to dietary fat, and the sphincter of Oddi regulates flow into the duodenum.

Disruption of bile flow produces cholestasis with systemic consequences. Bilirubin accumulates in plasma, bile acids are retained, and fat-soluble vitamin absorption becomes impaired in chronic obstruction. The enterohepatic circulation of bile acids means that serum concentrations reflect both hepatic synthesis and intestinal reabsorption. Determination of bile acids in canine biological samples emphasizes that interpretation of bile acid profiles must account for food composition, gastrointestinal transit times, and breed-specific variation, all of which influence measured values.

Pathophysiology of Gallbladder Disease

Gallbladder Mucocele

Gallbladder mucocele results from progressive accumulation of inspissated mucus within the gallbladder lumen. The underlying mechanism involves hyperplasia of mucus-secreting glands and impaired gallbladder motility, leading to a characteriztic sonographic appearance of stellate or striated bile. The condition is increasingly recognized as a distinct clinical entity with a breed predisposition that suggests a genetic component.

Mucocele formation is not benign. Progressive distension compromises gallbladder wall perfusion, leading to ischemia, necrosis, and eventual rupture. The risk of rupture correlates with wall thickness and the degree of luminal distension. Bile peritonitis from mucocele rupture carries substantial morbidity and requires emergency surgical management.

Cholecystitis

Cholecystitis refers to inflammation of the gallbladder wall and may be sterile or bacterial in origin. Chronic sterile cholecystitis can result from bile stasis, mucosal irritation, or extension of inflammation from adjacent organs. Bacterial cholecystitis typically arises from ascending enteric organizms, with Escherichia coli, Enterococcus species, and anaerobes commonly isolated.

The diagnostic value of macroscopic bile examination remains uncertain. A study of chronic cholecystitis in formerly bile-farmed Asiatic black bears found that bile color, viscosity, and turbidity did not reliably predict cytologic or culture evidence of bactibilia, and samples with cytologic bactibilia frequently lacked inflammatory cells. These findings caution against relying on visual bile assessment alone when deciding whether antimicrobial therapy is indicated.

Diagnostic Imaging

Ultrasonography

Abdominal ultrasound is the first-line imaging modality for suspected gallbladder disease. The gallbladder is readily identified in the right cranial abdomen, and assessment should include wall thickness, luminal content, biliary duct diameter, and pericholecystic fat appearance. Normal gallbladder wall thickness is generally less than 2 mm, though measurement varies with gallbladder distension and patient size.

Mucocele staging systems based on ultrasonographic appearance help guide management decisions. Early mucoceles show echogenic bile with a stellate pattern, while advanced lesions demonstrate a distinct echogenic mass with a hypoechoic rim. The presence of a discontinuous wall, pericholecystic fluid, or free abdominal fluid raises concern for rupture and mandates surgical evaluation.

Advanced Imaging

Endoscopic retrograde cholangiopancreatography (ERCP) provides direct visualization of the biliary tree and offers therapeutic options through endoscopic sphincterotomy. Diagnostic and therapeutic ERCP in dogs with suspected hepatobiliary disorders demonstrated that ERCP findings of ductal structures aligned with histopathology more often than ultrasonographic findings did, though the opposite was true for the gallbladder itself. This modality is particularly useful when extrahepatic biliary obstruction is suspected but ultrasonography is inconclusive.

Laboratory Evaluation

Bile Acid Testing

Serum bile acid measurement remains a standard component of hepatobiliary evaluation. Fasting and 2-hour postprandial samples are typically collected, and elevations suggest either hepatic dysfunction or cholestasis. However, the diagnostic significance of bile acids in canine biological samples highlights that consensus regarding optimal matrices and diagnostic thresholds remains elusive. Bile acids can be measured in blood, feces, urine, liver tissue, and gallbladder bile, yet interpretation is complicated by sampling challenges and physiologic variation.

In gallbladder disease specifically, bile acid elevations reflect impaired bile flow instead of hepatocellular failure. Marked elevations with normal hepatic architecture on ultrasound suggest extrahepatic obstruction. Serial bile acid measurements can monitor response to medical therapy, though they do not distinguish mucocele from cholecystitis or neoplasia.

Additional Laboratory Parameters

Complete blood count, serum biochemistry, and coagulation testing are essential in any patient with suspected biliary disease. Leukocytosis with left shift supports bacterial infection, while thrombocytopenia or prolonged clotting times raise concern for sepsis or hepatic dysfunction. Serum bilirubin, alkaline phosphatase, and gamma-glutamyltransferase are typically elevated in cholestasis, but these markers lack specificity for gallbladder disease. C-reactive protein may be useful as an inflammatory marker, though it does not differentiate biliary inflammation from other sources.

Medical Management of Gallbladder Disease

Medical therapy targets three overlapping goals: reducing bile stasis, controlling bacterial infection, and limiting inflammation. The choice of agents and the duration of therapy depend on the underlying disease process, the presence of extrahepatic biliary obstruction, and the patient's surgical candidacy.

Choleretics and Bile Flow Modulation

Ursodeoxycholic acid (UDCA) remains the most commonly used choleretic in canine gallbladder disease. Its mechanisms include displacing hepatotoxic bile acids, reducing bile viscosity, and stimulating hepatocyte bile secretion. UDCA is most rationally applied in cases of gallbladder mucocele, where bile stasis and altered mucin composition are central to pathogenesis, and in chronic cholecystitis where bile flow enhancement may reduce gallbladder residence time. The drug has minimal adverse effects, chiefly transient diarrhea, and is generally well tolerated in dogs.

S-adenosylmethionine (SAMe) is frequently co-administered for its antioxidant and hepatoprotective effects. Its role in primary gallbladder disease is less direct than in hepatocellular injury, but it is often included when concurrent hepatic pathology is suspected. Neither UDCA nor SAMe dissolves existing mucoceles, and clinicians should not expect medical therapy alone to resolve a sonographically established mucocele.

Antimicrobial Therapy

Antimicrobial selection requires distinction between empirical and culture-directed therapy. In acute cholecystitis or suspected bactibilia, empirical coverage should target enteric organizms, particularly Escherichia coli, Enterococcus spp., and anaerobes such as Clostridium and Bacteroides. Amoxicillin-clavulanate or a fluoroquinolone combined with metronidazole are common empirical choices. Current formulary and label references must be consulted for dosing and duration.

Definitive therapy follows bile culture and susceptibility testing. Bile samples obtained by ultrasound-guided cholecystocentesis or at surgery provide the most reliable culture material. The correlation between macroscopic bile appearance and infection is imperfect. In a study of formerly bile-farmed bears with chronic cholecystitis, samples with cytological evidence of bactibilia often lacked inflammatory cells, and macroscopic findings did not consistently predict culture results. This observation supports routine culture submission whenever bile is aspirated, regardless of its gross appearance.

Duration of antimicrobial therapy for bacterial cholecystitis is not firmly established in dogs. Human and bear data suggest that prolonged courses, often four to six weeks, may be required to clear chronic infection. Repeat bile sampling during or after therapy can document bacteriologic cure, though this is rarely performed in clinical practice. Clinical response, serial ultrasonography, and inflammatory marker trends guide treatment duration.

Anti-Inflammatory and Adjunctive Therapy

Corticosteroids are reserved for neutrophilic or lymphoplasmacytic cholecystitis without evidence of bacterial infection or biliary obstruction. Their use in septic cholecystitis is contraindicated. When sterile inflammation is confirmed or strongly suspected, prednisone at anti-inflammatory doses may reduce mural thickening and improve clinical signs. The decision to use corticosteroids should be revisited if the patient deteriorates, as immunosuppression may unmask or exacerbate bacterial disease.

Analgesia is an underappreciated component of gallbladder disease management. Visceral pain from gallbladder distension or mural inflammation responds to full mu-opioid agonists in acute presentations. Nonsteroidal anti-inflammatory drugs are generally avoided in patients with suspected hepatic compromise or dehydration due to renal and hepatic perfusion concerns.

Surgical Decision-Making

Surgery is the definitive treatment for gallbladder mucocele, gallstone-related obstruction, and complicated cholecystitis. The decision to operate rests on the presence of extrahepatic biliary obstruction, the risk of gallbladder rupture, and the failure of medical management.

Indications for Cholecystectomy

Cholecystectomy is indicated for confirmed or suspected gallbladder rupture, extrahepatic bile duct obstruction, and mucoceles with sonographic evidence of wall compromise or pericholecystic fluid. The decision is more nuanced for asymptomatic or incidentally detected mucoceles. Serial ultrasonography every four to six weeks can document progression. Mucoceles that enlarge, develop wall thickening, or produce clinical signs warrant surgical referral.

Gallbladder mucocele carries a risk of rupture that is difficult to predict sonographically. A distended, thin-walled gallbladder with echogenic bile and pericholecystic inflammation is higher risk. The presence of a "kiwi" or stellate pattern, while characteriztic, does not by itself mandate surgery. Patient factors such as age, comorbidities, and owner resources influence the timing of intervention.

Surgical Techniques and Perioperative Care

Cholecystectomy is performed via midline celiotomy. Laparoscopic cholecystectomy is feasible in selected cases but requires specialized equipment and experience. Open surgery remains the standard for complicated disease, particularly when bile peritonitis or concurrent biliary diversion is anticipated.

Perioperative management includes intravenous fluid therapy, antimicrobials continued from the preoperative period, and close monitoring for hypotension and coagulopathy. Postoperative complications include bile leakage, pancreatitis, and persistent biliary obstruction. In a case report of a geriatric dog with hepatic abscess and congenital portosystemic shunt, combined partial hepatic lobectomy, cholecystectomy, and shunt attenuation was performed after targeted antimicrobial therapy failed, and the dog recovered uneventfully. This case illustrates that surgical intervention may be required when medical therapy cannot control infection, particularly when hepatic perfusion is impaired.

When Surgery Is Not Appropriate

Surgery is contraindicated in patients with severe coagulopathy, end-stage hepatic failure, or prohibitive anesthetic risk. In these patients, medical management with UDCA, antimicrobials, and supportive care may provide palliation. Percutaneous cholecystostomy or endoscopic drainage are alternative interventions in select cases. Endoscopic retrograde cholangiopancreatography with sphincterotomy has been described in dogs with suspected hepatobiliary disorders and may relieve distal bile duct obstruction without surgery. In a retrospective series, ERCP findings of ductal structures agreed with pathology more often than ultrasonography did, though the reverse was noted for the gallbladder. This technique requires specialized equipment and expertise and is not widely available.

Monitoring and Follow-Up

Serial ultrasonography is the primary monitoring tool. Gallbladder wall thickness, luminal content, bile duct diameter, and the presence of free abdominal fluid should be assessed at each examination. Clinical improvement should correlate with sonographic changes, persistent wall thickening or ductal dilation despite clinical improvement warrants investigation.

Serum bile acid measurement has limited utility in monitoring gallbladder disease specifically. Bile acid profiles are influenced by food composition, transit times, and breed-specific variation, and consensus on diagnostic thresholds remains elusive. Bile acids are more useful for assessing hepatic function than for tracking gallbladder pathology.

Inflammatory markers such as C-reactive protein may aid in monitoring response to therapy. In the hepatic abscess case report, rising C-reactive protein despite targeted antimicrobial therapy prompted surgical intervention. Serial measurement can therefore identify patients failing medical management before clinical deterioration becomes obvious.

Prognosis and Outcome

Prognosis depends on the underlying disease and the timing of intervention. Dogs with uncomplicated cholecystitis that respond to medical therapy generally have a good outcome. Dogs with gallbladder mucocele that undergo elective cholecystectomy before rupture have a favorable prognosis. Rupture with bile peritonitis carries a guarded prognosis, with outcome dependent on the speed of surgical intervention and the severity of peritonitis.

Chronic cholecystitis may require prolonged antimicrobial therapy and can recur. Repeat ultrasonography and bile culture are indicated if clinical signs return. The evidence base for long-term outcomes in canine gallbladder disease is limited, and clinicians should counsel owners that recurrence is possible even after apparently successful treatment.

Documentation and Communication

Medical records should document the sonographic appearance of the gallbladder, bile duct diameter, wall thickness, and the presence of any pericholecystic fluid. Serial measurements allow objective assessment of progression. Bile culture results, antimicrobial susceptibility, and the duration of therapy should be recorded clearly. When surgery is discussed but declined, the discussion and the owner's decision should be documented.

Communication with owners should address the risk of rupture, the expected response to medical therapy, and the signs that warrant immediate re-evaluation. Owners should understand that medical management of a mucocele is a holding strategy, not a cure, and that surgical referral may become necessary.

Recognized Complications and Early Detection

Gallbladder disease in dogs follows a limited set of failure trajectories, and each has identifiable prodromes. Biliary rupture is the most consequential. Suspect it when serial ultrasonography shows loss of gallbladder wall definition, free peritoneal fluid, or a hyperechoic omentum adjacent to the liver. Abdominocentesis with fluid bilirubin concentration exceeding serum bilirubin confirms the diagnosis. Peritonitis from bile is chemical before it becomes septic, so cytology may initially show sterile neutrophilic inflammation, repeat sampling is warranted if clinical signs progress.

Cholecystitis progressing to gallbladder necrosis or empyema presents with worsening fever, progressive leukocytosis, and increasing gallbladder wall thickness on ultrasound. The wall may become irregular or hypoechoic in segments, indicating mural compromise. Hepatic abscess formation adjacent to the gallbladder has been reported in dogs with impaired hepatic perfusion, and persistent pyrexia despite antimicrobial therapy should prompt re-imaging of the liver parenchyma, also the biliary tree (Multidisciplinary Surgical Treatment of Hepatic Abscess in a Geriatric Dog with Congenital Extrahepatic Portosystemic Shunt).

Post-cholecystectomy bile leakage presents with progressive abdominal effusion, hypoalbuminemia, and rising peritoneal fluid bilirubin in the first 72 hours after surgery. Cholangiohepatitis ascending from biliary stasis is detected by rising liver enzyme activities, particularly ALP and GGT, with or without hyperbilirubinemia. Serial bile acid measurements are not useful for detecting these complications because they reflect hepatocellular function instead of biliary integrity (Determination of Bile Acids in Canine Biological Samples: Diagnostic Significance).

Common Diagnostic Errors

The most frequent error is over-reliance on gallbladder appearance alone. A distended, thin-walled gallbladder with echogenic bile may represent normal fasting physiology instead of stasis. Conversely, a small, contracted gallbladder can be mistaken for disease when the patient has recently eaten. Always interpret gallbladder findings in the context of fasting status and concurrent hepatic changes.

A second error is treating ultrasonographic gallbladder sludge as an indication for surgery. Sludge alone, without wall thickening, biliary dilation, or clinical signs, does not mandate cholecystectomy. The decision to operate rests on evidence of obstruction, inflammation, or rupture risk, not on the presence of sediment.

A third error is using bile acid testing to stage biliary disease. Bile acids assess portosystemic shunting and hepatocellular function, they do not quantify biliary obstruction or inflammation. A dog with complete extrahepatic biliary obstruction can have normal fasting bile acids if hepatocellular function is preserved. Reserve bile acid testing for suspected shunt or hepatopathy, and rely on bilirubin, ALP, GGT, and imaging for biliary assessment (A review of disorders of the gallbladder and extrahepatic biliary tract in the dog and cat).

Finally, inexperienced clinicians often delay surgical referral while pursuing medical management in a deteriorating patient. Serial ultrasound showing progressive gallbladder wall thickening, increasing common bile duct diameter, or new peritoneal effusion should trigger referral, not another round of antibiotics.

Evidence Limitations and Divergent Expert Opinion

The veterinary literature on gallbladder disease is dominated by retrospective case series and expert opinion. Prospective randomised trials comparing medical versus surgical management of mucocele are lacking, and the natural history of asymptomatic mucocele remains poorly defined. Consequently, thresholds for prophylactic cholecystectomy vary substantially between institutions and individual surgeons.

Bile acid interpretation remains contested. Sampling matrix, fed versus fasted status, and breed-specific variation all influence results, and consensus on diagnostic thresholds has not been reached (Determination of Bile Acids in Canine Biological Samples: Diagnostic Significance). Similarly, the role of endoscopic retrograde cholangiopancreatography in dogs is still being defined, it offers superior ductal assessment compared with ultrasound but requires specialised equipment and expertise (Diagnostic value of endoscopic retrograde cholangiopancreatography and therapeutic value of endoscopic sphincterotomy in dogs with suspected hepatobiliary disorders).

Antimicrobial selection for cholecystitis is another area of divergence. Some authorities recommend empirical therapy pending culture, while others insist on cholecystocentesis before starting antibiotics. The risk of sampling complications must be weighed against the benefit of targeted therapy. Where bile culture is obtained, sensitivity testing should guide ongoing treatment, but the optimal duration of therapy remains undefined.

Referral and Escalation Criteria

Refer for specialist evaluation when any of the following are present: suspected biliary rupture, common bile duct obstruction, gallbladder wall necrosis, or failure to improve within 48 hours of medical therapy. Surgical consultation is also appropriate for recurrent cholecystitis, suspected neoplastic disease of the biliary tract, or when ultrasound-guided cholecystocentesis is considered high risk due to gallbladder wall thinning or coagulopathy.

Laboratory involvement is warranted when bile culture yields unusual organizms, when antimicrobial susceptibility testing shows multidrug resistance, or when histopathology of a resected gallbladder reveals unexpected findings such as neoplasia. Clinical pathologists can also assist with interpretation of peritoneal fluid analysis in equivocal cases of bile peritonitis.

Regulatory reporting is rarely required for canine gallbladder disease. However, if a bile culture yields an organizm with public health significance, such as certain Salmonella species, local public health authorities should be notified according to regional requirements. The WOAH terrestrial animal health standards provide general guidance on reportable diseases, though canine biliary disease is not typically included. Practitioners should consult AVMA practice resources for current professional guidance on reporting obligations in their jurisdiction.

Frequently Asked Questions

How Should I Manage Gallbladder Disease When Advanced Imaging or Endoscopy Is Unavailable?

When ERCP and advanced imaging are not accessible, ultrasonography remains the first-line modality for evaluating the canine hepatobiliary system, as noted in a study of endoscopic retrograde cholangiopancreatography in dogs with suspected hepatobiliary disorders. Serial ultrasound examinations can track gallbladder wall thickness, biliary distension, and mucocele progression. Medical management with choleretics, antimicrobials, and supportive care proceeds according to the same principles used when advanced tools are available. Surgical referral should be considered early for cases with suspected common bile duct obstruction, gallbladder rupture, or progressive clinical deterioration. Routine clinicopathologic monitoring, including serial bile acid measurements and inflammatory markers, helps compensate for the absence of direct ductal visualization.

What Are the Practical Limitations of Bile Acid Testing in Clinical Practice?

Bile acid interpretation requires attention to sampling timing, prandial state, and breed-specific variation, as emphasized in a review of bile acid determination in canine biological samples. Postprandial samples must be collected at the appropriate interval after a standardized meal, and results should be interpreted alongside liver enzyme activities and histopathology when available. Fasting and postprandial bile acid concentrations can overlap between healthy dogs and those with mild hepatobiliary disease, so a single normal result does not exclude clinically significant gallbladder pathology. The review also notes that consensus on optimal diagnostic thresholds remains elusive, and that matrix selection, whether serum, bile, or feces, influences interpretation. Use bile acids as one component of a broader diagnostic evaluation instead of as a standalone screening test.

How Do I Explain the Difference Between Medical and Surgical Management to an Owner?

Owners need a clear framework for why some gallbladder diseases respond to medication while others require surgery. Explain that medical therapy aims to improve bile flow and control infection, but cannot reverse structural changes such as a ruptured gallbladder or a completely obstructed bile duct. Describe the imaging findings that support each recommendation, such as a distended common bile duct or evidence of pericholecystic fluid. The decision to proceed to cholecystectomy is guided by recognized indications including obstruction, rupture, and failure of medical therapy, consistent with the surgical decision-making framework in the ACVIM consensus statements. Be honest about the uncertainty inherent in managing mucoceles, where the risk of progression must be weighed against surgical morbidity.

What Should I Document When Managing a Gallbladder Disease Case Longitudinally?

Maintain a structured medical record that captures initial diagnostic findings, treatment decisions, and response to therapy. Record serial ultrasound measurements, including gallbladder wall thickness, biliary diameter, and mucocele grade, using consistent terminology so that comparisons over time are meaningful. Document antimicrobial choices, duration of therapy, and any culture and susceptibility results. Note owner-reported signs such as vomiting, anorexia, or lethargy at each recheck, and record body weight and physical examination findings. The AVMA practice resources provide general guidance on medical record standards that support continuity of care and defensible clinical decision-making. Clear documentation also facilitates referral when surgical intervention becomes necessary.

How Does Gallbladder Disease Management Differ in Species Other Than Dogs?

Species differences in biliary physiology and disease presentation require adjustment of diagnostic and therapeutic approaches. In cats, cholecystitis and extrahepatic biliary obstruction carry a more guarded prognosis, and the threshold for surgical intervention differs. A study of chronic cholecystitis in formerly bile-farmed Asiatic black bears found that macroscopic bile examination, including color, viscosity, and turbidity, did not consistently correlate with cytological evidence of bactibilia, highlighting the limitations of visual bile assessment across species. The MSD Veterinary Manual provides species-specific guidance on biliary disease presentation and management. Clinicians should not assume that canine treatment protocols, particularly antimicrobial durations and surgical criteria, translate directly to other species.

How Should I Approach a Case Where the Owner Declines Surgery for a Ruptured Gallbladder?

When surgery is declined for a confirmed or suspected gallbladder rupture, the conversation should shift to realistic goals of care. Medical management with broad-spectrum antimicrobials, fluid therapy, and analgesia may provide temporary stabilization, but the underlying bile peritonitis will persist and the risk of deterioration remains high. Document the owner's decision, the discussion of risks and benefits, and the recommended monitoring plan. Offer a recheck schedule that includes serial ultrasound and clinicopathologic assessment, and provide clear criteria for emergency re-presentation. The WOAH terrestrial animal health standards do not address this specific clinical scenario, but general professional standards for informed consent and documentation apply. Palliative options should be discussed honestly, including the expected disease trajectory without surgical intervention.

Related Clinical & Scientific Guides

• Feline Hepatic Lipidosis: Nutritional and Medical Management
• Canine Respiratory Infection: Diagnostic Approach and Treatment
• Canine Respiratory Virus: Diagnostic and Management Considerations

References and Further Reading

• A review of disorders of the gallbladder and extrahepatic biliary tract in the dog and cat.. 1992.
• Determination of Bile Acids in Canine Biological Samples: Diagnostic Significance.. 2024.
• Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges.. 2016.
• Chronic cholecystitis: Diagnostic and therapeutic insights from formerly bile-farmed Asiatic black bears (Ursus thibetanus).. 2022.
• Multidisciplinary Surgical Treatment of Hepatic Abscess in a Geriatric Dog with Congenital Extrahepatic Portosystemic Shunt.. 2026.
• Diagnostic value of endoscopic retrograde cholangiopancreatography and therapeutic value of endoscopic sphincterotomy in dogs with suspected hepatobiliary disorders.. 2022.
• ACVIM Consensus Statements. Journal of Veterinary Internal Medicine.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.

Related Articles

• Canine Inflammatory Bowel Disease: Diagnostic and Therapeutic Approach
• Canine Respiratory Disease Complex: Diagnostic and Therapeutic Approach
• Canine Immune-Mediated Myositis: Diagnostic and Therapeutic Approach
• Canine Immune-Mediated Skin Disease: Diagnostic and Management Approach
• Canine Lung Disease: Differential Diagnosis and Diagnostic Approach

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.